Effects of ranolazine on recurrent cardiovascular events in patients with non–ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

DA Morrow, BM Scirica, E Karwatowska-Prokopczuk… - Jama, 2007 - jamanetwork.com
ContextRanolazine is a novel antianginal agent that reduces ischemia in patients with
chronic angina but has not been studied in patients with acute coronary syndromes (ACS) …

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial.

DA Morrow, BM Scirica, E Karwatowska-Prokopczuk… - JAMA, 2007 - europepmc.org
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation
acute coronary syndromes: the MERLIN-TIMI 36 randomized trial. - Abstract - Europe PMC …

[PDF][PDF] Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes

DA Morrow, BM Scirica, E Karwatowska-Prokopczuk… - JAMA, 2007 - researchgate.net
Objective To determine the efficacy and safety of ranolazine during long-term treatment of
patients with non–ST-elevation ACS. Design, Setting, and Patients A randomized, double …

Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non-ST-Elevation Acute Coronary Syndromes.

DA Morrow, BM Scirica… - JAMA: Journal of …, 2007 - search.ebscohost.com
The article presents a randomized controlled trial that examined the effects of the antianginal
drug ranolazine in the long-term treatment of patients with non-ST-elevation acute coronary …

[引用][C] Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: The MERLIN-TIMI 36 randomized trial …

DA MORROW, BM SCIRICA… - JAMA, the journal of …, 2007 - pascal-francis.inist.fr
Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation
acute coronary syndromes : The MERLIN-TIMI 36 randomized trial. Commentary CNRS Inist …

[引用][C] Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes The MERLIN-TIMI 36 Randomized …

DA Morrow - JAMA, 2007 - cir.nii.ac.jp
Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation
Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE> …

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

DA Morrow, BM Scirica, E Karwatowska-Prokopczuk… - 2007 - pubmed.ncbi.nlm.nih.gov
Context Ranolazine is a novel antianginal agent that reduces ischemia in patients with
chronic angina but has not been studied in patients with acute coronary syndromes (ACS) …

[PDF][PDF] Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes

DA Morrow, BM Scirica, E Karwatowska-Prokopczuk… - JAMA, 2007 - academia.edu
Objective To determine the efficacy and safety of ranolazine during long-term treatment of
patients with non–ST-elevation ACS. Design, Setting, and Patients A randomized, double …